A new "highly accurate" blood test for Alzheimer's disease also measures how far it has progressed. It could help enable ...

A potential new biomarker for predicting future cognitive resilience versus decline among people with early Alzheimer's ...

For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...

Megan Alford raises awareness about amyloidosis, a rare disease that can lead to organ failure, after her mother's diagnosis ...

For years, Alzheimer’s disease has been considered a brain disorder that leads to memory loss and cognitive decline. It’s a ...

Two UIC professors list their questions for the man set to lead "the crown jewel” of American biomedical science.

A new study conducted by researchers from the Washington University School of Medicine identified an experimental drug that ...

The drug, gantenerumab, was abandoned by its developers, but subsequent anti-amyloid drugs lecanemab ( Leqembi) and donanemab ...

Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...

(CNN) — For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains of people destined to develop Alzheimer’s dementia can ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

Cardiac amyloidosis (CA) is a restrictive cardiomyopathy characterized by the extracellular deposition of proteins in the myocardium. Transthyretin (TTR) protein is predominantly synthesized in the ...